3TR aims to provide fundamental new insights into the mechanisms of response and non-response to treatment. In doing so, we challenge the conventional ‘one-disease’ approach, in which diseases are classified according to their end-organ involvement rather than the molecular pathways that underpin them.

Accordingly, we propose a paradigm shift in the way we view disease: By promoting evidence-based reasoning for treatment selection, rather than following the traditional trial-and-error approach, 3TR will have significant implications for the future treatment of patients and the evaluation of the efficacy, safety and quality of future medical devices.

 

Code: IHRC22/00007

Funding entity: Comisión Europea

Competitive: Si

Center: GENYO

Time of implementation: 01/09/2019 – 01/08/2026

Principal Investigator: Dra. Marta Alarcón

More information: https://3tr-imi.eu/

 

Other international projects